Skip to main content
Caplight Logo









Droia Ventures

Droia Ventures

Meise, Flandersdroiaventures.com

Overview

Droia Ventures is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease . Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients . With a team of seasoned scientists, entrepreneurs and investment professionals, Droia builds companies to save patients' lives .

Year Founded

2011

Portfolio Companies

23

Investments

Droia Ventures investments
CompanyDateStageLead
Alesta TherapeuticsJan 2025Series ALead
Convert PharmaceuticalsFeb 2018Series ACo-investor
Volastra TherapeuticsMar 2023Series ACo-investor
Judo BioOct 2024Series ALead
Vicinitas TherapeuticsJul 2022Series ACo-investor
Book a demo to see all 23 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Droia Ventures based?

Droia Ventures is headquartered in Meise, Flanders, Belgium.

When was Droia Ventures founded?

Droia Ventures was founded in 2011.

How many portfolio companies does Droia Ventures have?

Droia Ventures has 23 portfolio companies in Caplight's dataset.

What are some companies in Droia Ventures's portfolio?

Portfolio companies visible on Caplight include Alesta Therapeutics, Convert Pharmaceuticals, Volastra Therapeutics, Judo Bio, Vicinitas Therapeutics.

What was Droia Ventures's most recent investment shown here?

Droia Ventures's most recent investment in this portfolio sample was in Alesta Therapeutics in 2025.

What sectors does Droia Ventures focus on?

Droia Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, FinTech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.

What company stages does Droia Ventures focus on?

Droia Ventures typically invests at the Early stage.

What is Droia Ventures's AUM?

Droia Ventures's assets under management are estimated between $250.0M and $500.0M.

Firmographic Details

HeadquartersMeise, Flanders
Year Founded2011

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?